Role of leptin in the pancreatic β-cell: Effects and signaling pathways

Journal of Molecular Endocrinology

Volumn 49, Issue 1, 2012, Pages

  Marroquí, Laura ^a,b   Gonzalez, Alejandro ^a,b   Nẽco, Patricia ^a,b   Caballero Garrido, Ernesto ^a,b   Vieira, Elaine ^a,b   Ripoll, Cristina ^a,b   Nadal, Angel ^a,b   Quesada, Ivan ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; LEPTIN; LEPTIN RECEPTOR; PHOSPHODIESTERASE III; STAT PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

APOPTOSIS; BLOOD BRAIN BARRIER; BODY WEIGHT; CELL PROLIFERATION; CELL SIZE; ENDOPLASMIC RETICULUM STRESS; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HORMONE BINDING; HORMONE RESISTANCE; HORMONE RESPONSE; HORMONE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; CELL SIZE; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LEPTIN; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION;

EID: 84863535816     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0025     Document Type: Review

References (80)

1. Ahren B & Havel PJ 1999 Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells). American Journal of Physiology 277 R959-R966.
2. Berti L, Kellerer M, Capp E & Haring HU 1997 Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect. Diabetologia 40 606-609.(doi:10.1007/s001250050722)
3. Brown JE & Dunmore SJ 2007 Leptin decreases apoptosis and alters BCL-2: Bax ratio in clonal rodent pancreatic b-cells. Diabetes/ Metabolism Research and Reviews 23 497-502. (doi:10.1002/dmrr.726)
4. Brown JE, Thomas S, Digby JE & Dunmore SJ 2002 Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS Letters 513 189-192. (doi:10.1016/S0014-5793(02)02296-2)
5. Cases JA, Gabriely I, Ma XH, Yang XM, Michaeli T, Fleischer N, Rossetti L & Barzilai N 2001 Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 50 348-352.(doi:10.2337/diabetes.50.2.348)
6. Ceddia RB, Lopes G, Souza HM, Borba-Murad GR, William WN Jr, Bazotte RB & Curi R 1999a Acute effects of leptin on glucose metabolism of in situ rat perfused livers and isolated hepatocytes. International Journal of Obesity and Related Metabolic Disorders 23 1207-1212. (doi:10.1038/sj.ijo.0801095)
7. Ceddia RB, William WN Jr & Curi R 1999b Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. International Journal of Obesity and Related Metabolic Disorders 23 75-82.(doi:10.1038/sj.ijo.0800762)
8. Chen NG, Swick AG & Romsos DR 1997 Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. Journal of Clinical Investigation 100 1174-1179.(doi:10.1172/JCI119629)
9. Chinookoswong N, Wang JL & Shi ZQ 1999 Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 48 1487-1492. (doi:10.2337/diabetes.48.7.1487)
10. Coppari R, Ichinose M, Lee CE, Pullen AE, Kenny CD, McGovern RA, Tang V, Liu SM, Ludwig T, Chua SC Jr et al. 2005 The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metabolism 1 63-72.(doi:10.1016/j.cmet.2004.12.004)
11. Covey SD, Wideman RD, McDonald C, Unniappan S, Huynh F, Asadi A, Speck M, Webber T, Chua SC & Kieffer TJ 2006 The pancreatic b cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metabolism 4 291-302. (doi:10.1016/j.cmet.2006. 09.005)
12. Cummings BP, Bettaieb A, Graham JL, Stanhope KL, Dill R, Morton GJ, Haj FG & Havel PJ 2011 Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCDT2DM rats. PNAS 108 14670-14675. (doi:10.1073/pnas. 1107163108)
13. Denroche HC, Levi J, Wideman RD, Sequeira RM, Huynh FK, Covey SD & Kieffer TJ 2011 Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes 60 1414-1423. (doi:10.2337/db10-0958)
14. Dubuc PU 1976 The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 25 1567-1574.(doi:10.1016/0026-0495(76)90109-8)
15. Emilsson V, Liu YL, Cawthorne MA, Morton NM & Davenport M 1997 Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46 313-316. (doi:10.2337/diabetes.46.2.313)
16. Fehmann HC, Bode HP, Ebert T, Karl A & Goke B 1997a Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction. Hormone and Metabolic Research 29 572-576. (doi:10.1055/s-2007-979103)
17. Fehmann HC, Peiser C, Bode HP, Stamm M, Staats P, Hedetoft C, Lang RE & Goke B 1997b Leptin: a potent inhibitor of insulin secretion. Peptides 18 1267-1273. (doi:10.1016/S0196-9781(97)00135-6)
18. Fruhbeck G 2006 Intracellular signalling pathways activated by leptin. Biochemical Journal 393 7-20. (doi:10.1042/BJ20051578)
19. Fujikawa T, Chuang JC, Sakata I, Ramadori G & Coppari R 2010 Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. PNAS 107 17391-17396.(doi:10.1073/pnas.1008025107)
20. Genuth SM, Przybylski RJ & Rosenberg DM 1971 Insulin resistance in genetically obese, hyperglycemic mice. Endocrinology 88 1230-1238.(doi:10.1210/endo-88-5-1230)
21. German JP, Thaler JP, Wisse BE, Oh-I S, Sarruf DA, Matsen ME, Fischer JD, Taborsky GJ Jr, Schwartz MW & Morton GJ 2011 Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 152 394-404.(doi:10.1210/en.2010-0890)
22. Gray SL, Donald C, Jetha A, Covey SD & Kieffer TJ 2010 Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic b-cell leptin signaling. Endocrinology 151 4178-4186.(doi:10.1210/en.2010-0102)
23. Harvey J, Hardy SC, Irving AJ & Ashford ML 2000 Leptin activation of ATP-sensitive KC (KATP) channels in rat CRI-G1 insulinoma cells involves disruption of the actin cytoskeleton. Journal of Physiology 527 95-107. (doi:10.1111/j.1469-7793.2000.00095.x)
24. Hekerman P, Zeidler J, Korfmacher S, Bamberg-Lemper S, Knobelspies H, Zabeau L, Tavernier J & Becker W 2007 Leptin induces inflammation-related genes in RINm5F insulinoma cells. BMC Molecular Biology 8 41. (doi:10.1186/1471-2199-8-41)
25. Hill JW, Elias CF, Fukuda M, Williams KW, Berglund ED, Holland WL, Cho YR, Chuang JC, Xu Y, Choi M et al. 2010 Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metabolism 11 286-297. (doi:10.1016/j.cmet.2010.03.002)
26. Huo L, Gamber K, Greeley S, Silva J, Huntoon N, Leng XH & Bjorbaek C 2009 Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metabolism 9 537-547.(doi:10.1016/j.cmet.2009.05.003)
27. Islam MS, Morton NM, Hansson A & Emilsson V 1997 Rat insulinomaderived pancreatic b-cells express a functional leptin receptor that mediates a proliferative response. Biochemical and Biophysical Research Communications 238 851-855. (doi:10.1006/bbrc.1997.7399)
28. Islam MS, Sjoholm A & Emilsson V 2000 Fetal pancreatic islets express functional leptin receptors and leptin stimulates proliferation of fetal islet cells. International Journal of Obesity and Related Metabolic Disorders 24 1246-1253. (doi:10.1038/sj.ijo.0801370)
29. Karlsen AE, Ronn SG, Lindberg K, Johannesen J, Galsgaard ED, Pociot F, Nielsen JH, Mandrup-Poulsen T, Nerup J & Billestrup N 2001 Suppressor of cytokine signaling 3 (SOCS-3) protects b-cells against interleukin-1b- and interferon-gamma-mediated toxicity. PNAS 98 12191-12196. (doi:10.1073/pnas.211445998)
30. Kieffer TJ, Heller RS & Habener JF 1996 Leptin receptors expressed on pancreatic b-cells. Biochemical and Biophysical Research Communications 224 522-527. (doi:10.1006/bbrc.1996.1059)
31. Kieffer TJ, Heller RS, Leech CA, Holz GG & Habener JF 1997 Leptin suppression of insulin secretion by the activation of ATP-sensitive KC channels in pancreatic b-cells. Diabetes 46 1087-1093. (doi:10.2337/diabetes.46.6.1087)
32. Kojima S, Asakawa A, Amitani H, Sakoguchi T, Ueno N, Inui A & Kalra SP 2009 Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides 30 962-966. (doi:10.1016/j.peptides.2009.01.007)
33. Kuehnen P, Laubner K, Raile K, Schofl C, Jakob F, Pilz I, Path G & Seufert J 2011 Protein phosphatase 1 (PP-1)-dependent inhibition of insulin secretion by leptin in INS-1 pancreatic b-cells and human pancreatic islets. Endocrinology 152 1800-1808. (doi:10.1210/en.2010-1094)
34. Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ & Bloom SR 1997 Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. Journal of Clinical Investigation 100 2729-2736. (doi:10.1172/JCI119818)
35. Kushner JA, Haj FG, Klaman LD, Dow MA, Kahn BB, Neel BG & White MF 2004 Islet-sparing effects of protein tyrosine phosphatase- 1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes 53 61-66. (doi:10.2337/diabetes.53.1.61)
36. Lam NT, Cheung AT, Riedel MJ, Light PE, Cheeseman CI & Kieffer TJ 2004 Leptin reduces glucose transport and cellular ATP levels in INS-1 b-cells. Journal of Molecular Endocrinology 32 415-424. (doi:10.1677/jme.0.0320415)
37. Lam NT, Covey SD, Lewis JT, Oosman S, Webber T, Hsu EC, Cheung AT & Kieffer TJ 2006 Leptin resistance following overexpression of protein tyrosine phosphatase 1B in liver. Journal of Molecular Endocrinology 36 163-174. (doi:10.1677/jme.1.01937)
38. Laubner K, Kieffer TJ, Lam NT, Niu X, Jakob F & Seufert J 2005 Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic b-cells. Diabetes 54 3410-3417. (doi:10.2337/diabetes.54.12.3410)
39. Leclercq-Meyer V & Malaisse WJ 1998 Failure of human and mouse leptin to affect insulin, glucagon and somatostatin secretion by the perfused rat pancreas at physiological glucose concentration. Molecular and Cellular Endocrinology 141 111-118. (doi:10.1016/ S0303-7207(98)00087-2)
40. Lee YH, Magkos F, Mantzoros CS & Kang ES 2011 Effects of leptin and adiponectin on pancreatic b-cell function. Metabolism 60 1664-1672.(doi:10.1016/j.metabol.2011.04.008)
41. Levi J, Gray SL, Speck M, Huynh FK, Babich SL, Gibson WT & Kieffer TJ 2011 Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance. Endocrinology 152 3385-3395. (doi:10.1210/en.2011-0185)
42. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS et al. 1997 Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nature Medicine 3 575-579. (doi:10.1038/nm0597-575)
43. Lupi R, Marchetti P, Maffei M, Del Guerra S, Benzi L, Marselli L, Bertacca A & Navalesi R 1999 Effects of acute or prolonged exposure to human leptin on isolated human islet function. Biochemical and Biophysical Research Communications 256 637-641.(doi:10.1006/bbrc.1999.0384)
44. Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA & Donath MY 2004 Leptin modulates b cell expression of IL-1 receptor antagonist and release of IL-1b in human islets. PNAS 101 8138-8143. (doi:10.1073/pnas.0305683101)
45. Maedler K, Schulthess FT, Bielman C, Berney T, Bonny C, Prentki M, Donath MY & Roduit R 2008 Glucose and leptin induce apoptosis in human b-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB Journal 22 1905-1913. (doi:10.1096/fj.07-101824)
46. Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, Hamnvik OP & Koniaris A 2011 Leptin in human physiology and pathophysiology. American Journal of Physiology. Endocrinology andMetabolism 301 E567-E584. (doi:10.1152/ajpendo. 00315.2011)
47. Meyer C, Robson D, Rackovsky N, Nadkarni V & Gerich J 1997 Role of the kidney in human leptin metabolism. American Journal of Physiology 273 E903-E907.
48. Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF, Li H, Elmquist JK, Kennedy RT & Kulkarni RN 2007 Disruption of leptin receptor expression in the pancreas directly affects b cell growth and function in mice. Journal of Clinical Investigation 117 2860-2868. (doi:10.1172/JCI30910)
49. Morris DL & Rui L 2009 Recent advances in understanding leptin signaling and leptin resistance. American Journal of Physiology. Endocrinology and Metabolism 297 E1247-E1259. (doi:10.1152/ajpendo.00274.2009)
50. Morton GJ & Schwartz MW 2011 Leptin and the central nervous system control of glucose metabolism. Physiological Reviews 91 389-411.(doi:10.1152/physrev.00007.2010)
51. Morton GJ, Kaiyala KJ, Fisher JD, Ogimoto K, Schwartz MW & Wisse BE 2011 Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. American Journal of Physiology. Endocrinology and Metabolism 300 E392-E401. (doi:10.1152/ajpendo.00546.2010)
52. Myers MG Jr, Leibel RL, Seeley RJ & Schwartz MW 2010 Obesity and leptin resistance: distinguishing cause from effect. Trends in Endocrinology and Metabolism 21 643-651. (doi:10.1016/j.tem.2010.08.002)
53. Naito M, Fujikura J, Ebihara K, Miyanaga F, Yokoi H, Kusakabe T, Yamamoto Y, Son C, Mukoyama M, Hosoda K et al. 2011 Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes 60 2265-2273. (doi:10.2337/db10-1795)
54. Nave H, Mueller G, Siegmund B, Jacobs R, Stroh T, Schueler U, Hopfe M, Behrendt P, Buchenauer T, Pabst R et al. 2008 Resistance of Janus kinase-2dependent leptinsignalinginnatural killer (NK) cells: anovel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 149 3370-3378. (doi:10.1210/en.2007-1516)
55. Ning K, Miller LC, Laidlaw HA, Burgess LA, Perera NM, Downes CP, Leslie NR & Ashford ML 2006 A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic b-cells. EMBO Journal 25 2377-2387. (doi:10.1038/sj.emboj.7601118)
56. Okuya S, Tanabe K, Tanizawa Y & Oka Y 2001 Leptin increases the viability of isolated rat pancreatic islets by suppressing apoptosis. Endocrinology 142 4827-4830. (doi:10.1210/en.142.11.4827)
57. Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, Myers MG Jr & Ozcan U 2009 Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metabolism 9 35-51.(doi:10.1016/j.cmet.2008.12.004)
58. Pallett AL, Morton NM, Cawthorne MA & Emilsson V 1997 Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. Biochemical and Biophysical Research Communications 238 267-270. (doi:10.1006/bbrc.1997.7274)
59. Park S, Ahn IS & Kim DS 2010 Central infusion of leptin improves insulin resistance and suppresses b-cell function, but not b-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model. Life Sciences 86 854-862. (doi:10.1016/j.lfs.2010. 03.021)
60. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T & Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 540-543.(doi:10.1126/science.7624776)
61. Perez C, Fernandez-Galaz C, Fernandez-Agullo T, Arribas C, Andres A, Ros M & Carrascosa JM 2004 Leptin impairs insulin signaling in rat adipocytes. Diabetes 53 347-353. (doi:10.2337/diabetes.53.2.347)
62. Poitout V, Rouault C, Guerre-Millo M, Briaud I & Reach G 1998 Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. Endocrinology 139 822-826. (doi:10.1210/en.139. 3.822)
63. Prpic V, Watson PM, Frampton IC, Sabol MA, Jezek GE & Gettys TW 2003 Differential mechanisms and development of leptin resistance in A/J versus C57BL/6J mice during diet-induced obesity. Endocrinology 144 1155-1163. (doi:10.1210/en.2002-220835)
64. Sachdeva MM & Stoffers DA 2009 Minireview: meeting the demand for insulin: molecular mechanisms of adaptive postnatal b-cell mass expansion. Molecular Endocrinology 23 747-758. (doi:10.1210/me. 2008-0400)
65. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D Jr, Woods SC, Seeley RJ et al. 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45 531-535. (doi:10.2337/diabetes.45.4.531)
66. Seufert J 2004 Leptin effects on pancreatic b-cell gene expression and function. Diabetes 53 (Suppl 1) S152-S158. (doi:10.2337/diabetes. 53.2007.S152)
67. Seufert J, Kieffer TJ & Habener JF 1999a Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptindeficient ob/ob mice. PNAS 96 674-679. (doi:10.1073/pnas.96. 2.674)
68. Seufert J, Kieffer TJ, Leech CA, Holz GG, Moritz W, Ricordi C & Habener JF 1999b Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 84 670-676. (doi:10.1210/jc.84.2.670)
69. Shimabukuro M, Wang MY, Zhou YT, Newgard CB & Unger RH 1998 Protection against lipoapoptosis of b cells through leptin-dependent maintenance of Bcl-2 expression. PNAS 95 9558-9561. (doi:10.1073/pnas.95.16.9558)
70. Shimomura I, Hammer RE, Ikemoto S, Brown MS & Goldstein JL 1999 Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401 73-76. (doi:10.1038/43448)
71. Steinberg GR, Watt MJ, Fam BC, Proietto J, Andrikopoulos S, Allen AM, Febbraio MA & Kemp BE 2006 Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 147 3906-3914. (doi:10.1210/en.2005-1587)
72. Tanabe K, Okuya S, Tanizawa Y, Matsutani A & Oka Y 1997 Leptin induces proliferation of pancreatic b cell line MIN6 through activation of mitogen-activated protein kinase. Biochemical and Biophysical Research Communications 241 765-768. (doi:10.1006/ bbrc.1997.7894)
73. Tanizawa Y, Okuya S, Ishihara H, Asano T, Yada T & Oka Y 1997 Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic b cells. Endocrinology 138 4513-4516. (doi:10.1210/en.138.10.4513)
74. Tsiotra PC, Tsigos C & Raptis SA 2001 TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. International Journal of Obesity and Related Metabolic Disorders 25 1018-1026. (doi:10.1038/sj.ijo. 0801657)
75. Wang MY, Koyama K, Shimabukuro M, Mangelsdorf D, Newgard CB & Unger RH 1998a Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. PNAS 95 11921-11926.(doi:10.1073/pnas.95.20.11921)
76. Wang MY, Koyama K, Shimabukuro M, Newgard CB & Unger RH 1998b OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. PNAS 95 714-718. (doi:10.1073/pnas. 95.2.714)
77. Wang MY, Chen L, Clark GO, Lee Y, Stevens RD, Ilkayeva OR, Wenner BR, Bain JR, Charron MJ, Newgard CB et al. 2010 Leptin therapy in insulin-deficient type I diabetes. PNAS 107 4813-4819.(doi:10.1073/pnas.0909422107)
78. Yu X, Park BH, Wang MY, Wang ZV & Unger RH 2008 Making insulindeficient type 1 diabetic rodents thrive without insulin. PNAS 105 14070-14075.(doi:10.1073/pnas.0806993105)
79. Zhang X, Zhang G, Zhang H, Karin M, Bai H & Cai D 2008 Hypothalamic IKKb/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135 61-73. (doi:10.1016/j.cell.2008.07.043)
80. Zhao AZ, Bornfeldt KE & Beavo JA 1998 Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. Journal of Clinical Investigation 102 869-873. (doi:10.1172/JCI3920)